Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil

Detalhes bibliográficos
Autor(a) principal: Garbin, Clea Adas Saliba
Data de Publicação: 2021
Outros Autores: Oliveira, Julio Martinez Alves, Saliba, Tânia Adas, Dias, Gabriel Zopolatto Turci, Garbin, Artênio José Isper
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/17041
Resumo: With the declaration of the new Coronavirus pandemic (COVID-19) by the World Health Organization (WHO), onMarch 11, 2020, the escalation by research on possible strategies for its confrontation has reached a new level. The objective of this study was to evaluate the coverage of health insurance companies in relation to COVID-19 tests determined by the National Supplementary Health Agency (ANS) and to analyze the number of COVID-19 tests performed in Brazil. This is a documentary, ecological study, which was carried out from March 2020 to March 2021. The data released by the National Supplementary Health Agency was verified in relation to the tests included in the List of Procedures and Events in Health of ANS. In the state health departments, the number of tests performed daily in Brazil was analyzed. During this period 07 tests were implemented by ANS: SARS-CoV-2 (CORONAVIRUS COVID-19) - RT search - PCR (with usage guidelines), D-Dimer (dosage), Procalcitonin (dosage), Research tests rapid for Influenza A and B, and real-time PCR for Influenza A and B viruses in addition to the Quick Search tests for Respiratory Syncytial Virus and real-time PCR for Respiratory Syncytial Virus. The Southeast region carried out the largest number of tests in Brazil, with almost 50% of the total, followed by the Northeast region, which tested approximately 25% of the inhabitants. The types of tests determined by the ANS are in accordance with the recommendations of the Ministry of Health of Brazil, however, it is concluded that some health plan operators are not following the determination of the ANS in relation to the coverage of these tests, negatively influencing the number of tests carried out in the country.
id UNIFEI_cfca7d67ede39cf8d735f9b2da8034da
oai_identifier_str oai:ojs.pkp.sfu.ca:article/17041
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil Análisis de la cobertura de los planes de salud relacionados con las pruebas de detección de COVID-19 en Brasil Análise da cobertura dos planos de saúde médicos relacionados aos exames de detecção de COVID-19 no Brasil Infecções por coronavirusSaúde suplementarServiços de saúde.Infecciones por coronavirusSalud complementariaServicios de salud.Coronavirus infectionsSupplementary healthHealth services.With the declaration of the new Coronavirus pandemic (COVID-19) by the World Health Organization (WHO), onMarch 11, 2020, the escalation by research on possible strategies for its confrontation has reached a new level. The objective of this study was to evaluate the coverage of health insurance companies in relation to COVID-19 tests determined by the National Supplementary Health Agency (ANS) and to analyze the number of COVID-19 tests performed in Brazil. This is a documentary, ecological study, which was carried out from March 2020 to March 2021. The data released by the National Supplementary Health Agency was verified in relation to the tests included in the List of Procedures and Events in Health of ANS. In the state health departments, the number of tests performed daily in Brazil was analyzed. During this period 07 tests were implemented by ANS: SARS-CoV-2 (CORONAVIRUS COVID-19) - RT search - PCR (with usage guidelines), D-Dimer (dosage), Procalcitonin (dosage), Research tests rapid for Influenza A and B, and real-time PCR for Influenza A and B viruses in addition to the Quick Search tests for Respiratory Syncytial Virus and real-time PCR for Respiratory Syncytial Virus. The Southeast region carried out the largest number of tests in Brazil, with almost 50% of the total, followed by the Northeast region, which tested approximately 25% of the inhabitants. The types of tests determined by the ANS are in accordance with the recommendations of the Ministry of Health of Brazil, however, it is concluded that some health plan operators are not following the determination of the ANS in relation to the coverage of these tests, negatively influencing the number of tests carried out in the country.Con la declaración de la nueva pandemia de Coronavirus (COVID-19) por parte de la Organización Mundial de la Salud (OMS), el 11 de marzo de 2020, la escalada de investigaciones sobre posibles estrategias para su enfrentamiento ha alcanzado un nuevo nivel. El objetivo de este estudio fue evaluar la cobertura de las compañías de seguros de salud en relación a las pruebas COVID-19 determinadas por la Agencia Nacional de Salud Complementaria (ANS) y analizar el número de pruebas COVID-19 realizadas en Brasil. Se trata de un estudio documental, ecológico, que se realizó desde marzo de 2020 hasta marzo de 2021. Se verificaron los datos difundidos por la Agencia Nacional de Salud Complementaria en relación con las pruebas incluidas en la Lista de Procedimientos y Eventos en Salud de ANS. En los departamentos de salud estatales, se analizó el número de pruebas realizadas diariamente en Brasil. Durante este período, ANS implementó 07 pruebas: SARS-CoV-2 (CORONAVIRUS COVID-19) - Búsqueda de RT - PCR (con pautas de uso), D-Dimer (dosis), Procalcitonina (dosis), Pruebas de investigación rápidas para influenza A y B, y PCR en tiempo real para los virus de la influenza A y B, además de las pruebas de búsqueda rápida para virus sincitial respiratorio y PCR en tiempo real para virus sincitial respiratorio. La región Sudeste realizó la mayor cantidad de pruebas en Brasil, con casi el 50% del total, seguida de la región Nordeste, que evaluó aproximadamente al 25% de los habitantes. Los tipos de pruebas determinadas por la ANS están de acuerdo con las recomendaciones del Ministerio de Salud de Brasil, sin embargo, se concluye que algunos operadores de planes de salud no están siguiendo la determinación de la ANS en relación a la cobertura de estas pruebas, negativamente influyendo en el número de pruebas realizadas en el país.Com a declaração da pandemia do novo Coronavírus (COVID-19) pela Organização Mundial da Saúde (OMS), em 11 de março de 2020, a escalada por pesquisas sobre possíveis estratégias para o seu enfrentamento ganhou novo patamar. O objetivo neste estudo foi avaliar a cobertura das operadoras de planos de saúde em relação aos testes de COVID-19 determinada pela Agência Nacional de Saúde Suplementar (ANS) e analisar o número de exames de COVID-19 realizados no Brasil. Trata-se de um estudo documental, ecológico, que foi realizado do mês de março de 2020 à março de 2021. Verificou-se os dados divulgados pela ANS, com relação aos testes incluídos no Rol de Procedimentos e Eventos em Saúde. Já nas secretarias estaduais de saúde foram analisados o número de testes realizados diariamente no Brasil. Neste período foram implementados 07 testes pela ANS: o SARS-CoV-2 (CORONAVÍRUS COVID-19) – pesquisa por RT – PCR (com diretriz de utilização), o Dímero D (dosagem), o Procalcitonina (dosagem), os testes Pesquisa rápida para Influenza A e B ,e o PCR em tempo real para os vírus Influenza A e B além dos testes Pesquisa rápida para Vírus Sincicial Respiratório e o PCR em tempo real para Vírus Sincicial Respiratório. A região Sudeste realizou o maior número de testes no Brasil, com quase 50% do total, seguido pela região Nordeste, que testou aproximadamente 25% dos habitantes. Os tipos de testes determinados pela ANS estão de acordo com o recomendado pelo Ministério da Saúde do Brasil, entretanto, conclui-se que algumas operadoras de planos de saúde não estão seguindo a determinação da ANS em relação à cobertura destes exames influenciando negativamente no número de testes realizados no país.Research, Society and Development2021-07-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1704110.33448/rsd-v10i8.17041Research, Society and Development; Vol. 10 No. 8; e55510817041Research, Society and Development; Vol. 10 Núm. 8; e55510817041Research, Society and Development; v. 10 n. 8; e555108170412525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/17041/15338Copyright (c) 2021 Clea Adas Saliba Garbin; Julio Martinez Alves Oliveira; Tânia Adas Saliba; Gabriel Zopolatto Turci Dias; Artênio José Isper Garbinhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGarbin, Clea Adas Saliba Oliveira, Julio Martinez Alves Saliba, Tânia Adas Dias, Gabriel Zopolatto Turci Garbin, Artênio José Isper 2021-08-21T18:46:59Zoai:ojs.pkp.sfu.ca:article/17041Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:37:26.614628Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
Análisis de la cobertura de los planes de salud relacionados con las pruebas de detección de COVID-19 en Brasil
Análise da cobertura dos planos de saúde médicos relacionados aos exames de detecção de COVID-19 no Brasil
title Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
spellingShingle Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
Garbin, Clea Adas Saliba
Infecções por coronavirus
Saúde suplementar
Serviços de saúde.
Infecciones por coronavirus
Salud complementaria
Servicios de salud.
Coronavirus infections
Supplementary health
Health services.
title_short Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
title_full Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
title_fullStr Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
title_full_unstemmed Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
title_sort Analysis of coverage of medical health plans related to COVID-19 detection tests in Brazil
author Garbin, Clea Adas Saliba
author_facet Garbin, Clea Adas Saliba
Oliveira, Julio Martinez Alves
Saliba, Tânia Adas
Dias, Gabriel Zopolatto Turci
Garbin, Artênio José Isper
author_role author
author2 Oliveira, Julio Martinez Alves
Saliba, Tânia Adas
Dias, Gabriel Zopolatto Turci
Garbin, Artênio José Isper
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Garbin, Clea Adas Saliba
Oliveira, Julio Martinez Alves
Saliba, Tânia Adas
Dias, Gabriel Zopolatto Turci
Garbin, Artênio José Isper
dc.subject.por.fl_str_mv Infecções por coronavirus
Saúde suplementar
Serviços de saúde.
Infecciones por coronavirus
Salud complementaria
Servicios de salud.
Coronavirus infections
Supplementary health
Health services.
topic Infecções por coronavirus
Saúde suplementar
Serviços de saúde.
Infecciones por coronavirus
Salud complementaria
Servicios de salud.
Coronavirus infections
Supplementary health
Health services.
description With the declaration of the new Coronavirus pandemic (COVID-19) by the World Health Organization (WHO), onMarch 11, 2020, the escalation by research on possible strategies for its confrontation has reached a new level. The objective of this study was to evaluate the coverage of health insurance companies in relation to COVID-19 tests determined by the National Supplementary Health Agency (ANS) and to analyze the number of COVID-19 tests performed in Brazil. This is a documentary, ecological study, which was carried out from March 2020 to March 2021. The data released by the National Supplementary Health Agency was verified in relation to the tests included in the List of Procedures and Events in Health of ANS. In the state health departments, the number of tests performed daily in Brazil was analyzed. During this period 07 tests were implemented by ANS: SARS-CoV-2 (CORONAVIRUS COVID-19) - RT search - PCR (with usage guidelines), D-Dimer (dosage), Procalcitonin (dosage), Research tests rapid for Influenza A and B, and real-time PCR for Influenza A and B viruses in addition to the Quick Search tests for Respiratory Syncytial Virus and real-time PCR for Respiratory Syncytial Virus. The Southeast region carried out the largest number of tests in Brazil, with almost 50% of the total, followed by the Northeast region, which tested approximately 25% of the inhabitants. The types of tests determined by the ANS are in accordance with the recommendations of the Ministry of Health of Brazil, however, it is concluded that some health plan operators are not following the determination of the ANS in relation to the coverage of these tests, negatively influencing the number of tests carried out in the country.
publishDate 2021
dc.date.none.fl_str_mv 2021-07-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/17041
10.33448/rsd-v10i8.17041
url https://rsdjournal.org/index.php/rsd/article/view/17041
identifier_str_mv 10.33448/rsd-v10i8.17041
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/17041/15338
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 8; e55510817041
Research, Society and Development; Vol. 10 Núm. 8; e55510817041
Research, Society and Development; v. 10 n. 8; e55510817041
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052833149747200